Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 30.06.2025 1 Antimicrob Agents Chemother 1 Antiviral Res 1 Biochemistry 1 Cell 1 Epidemiol Infect 3 J Infect 2 J Infect Dis 1 MMWR Morb Mortal Wkly Rep 1 PLoS Biol 3 PLoS Comput Biol 20 PLoS One 2 Proc Natl Acad Sci U S A 4 Vaccine 3 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. MENG X, Zhang C, Wang X, Shi J, et al
   A branched peptide targets virus and host to block influenza virus and rhinovirus entry.
   Antimicrob Agents Chemother. 2025 Jun 25:e0002425. doi: 10.1128/aac.00024.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. HUSSAIN S, Meijer A, Govorkova EA, Dapat C, et al
   Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.
   Antiviral Res. 2025 Jun 24:106217. doi: 10.1016/j.antiviral.2025.106217.
   PubMed         Abstract available
   
   

   
   Biochemistry

3. PANKRATOVA Y, Hong M
   Side Chain Structures of the Proton-Selective Histidine and Gating Tryptophan in Influenza BM2 Reveal Both Conservation and Variation of the Proton Conduction Mechanism.
   Biochemistry. 2025 Jun 24. doi: 10.1021/acs.biochem.5c00242.
   PubMed         Abstract available
   
   

   
   Cell

4. DHENNI R, Hoppe AC, Reynaldi A, Kyaw W, et al
   Macrophages direct location-dependent recall of B cell memory to vaccination.
   Cell. 2025;188:3477-3496.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

5. COLEMAN BL, Robertson NM, Harrison RA, Valiquette L, et al
   Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.
   Epidemiol Infect. 2025;153:e72.
   PubMed         Abstract available
   
   

   
   J Infect

6. RIVERA-IZQUIERDO M, Verdejo-Ianez A, Morales-Portillo A, Gonzalez-Alcaide M, et al
   High-dose versus standard-dose influenza vaccine for immunocompromised patients: A systematic review and meta-analysis of randomised clinical trials.
   J Infect. 2025;91:106538.
   PubMed         Abstract available
   
   
7. WANG J, Guo S, Zhao J, Sun T, et al
   Host lncRNA assists the nuclear import of influenza A virus protein PB2 in a species-specific manner.
   J Infect. 2025;91:106540.
   PubMed         Abstract available
   
   
8. YANG J, Chen X, Li X, Zhang Y, et al
   Global spread of H3 subtype avian influenza viruses with an accelerated evolution after interspecies transmission.
   J Infect. 2025 Jun 20:106542. doi: 10.1016/j.jinf.2025.106542.
   PubMed         Abstract available
   
   

   
   J Infect Dis

9. GUILFOYLE K, Mirolo M, de Waal L, van Amerongen G, et al
   Highly Pathogenic Avian Influenza Virus A/H5N1 subclade 2.3.4.4 b isolated from a European grey seal (Halichoerus grypus) is highly virulent in ferrets.
   J Infect Dis. 2025 Jun 28:jiaf348. doi: 10.1093.
   PubMed         Abstract available
   
   
10. LU Y, Allen JD, Ross TM, Cowling B, et al
    Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge Trial.
    J Infect Dis. 2025 Jun 20:jiaf331. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

11. DIAZ MH, Hersh AL, Olson J, Shah SS, et al
    Mycoplasma pneumoniae Infections in Hospitalized Children - United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:394-400.
    PubMed         Abstract available
    
    

    
    PLoS Biol

12. YIN X, Pu Y, Yuan S, Pache L, et al
    Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection.
    PLoS Biol. 2025;23:e3002738.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

13. GAZEAU ST, Deng X, Brunet-Ratnasingham E, Kaufmann DE, et al
    Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.
    PLoS Comput Biol. 2025;21:e1013170.
    PubMed         Abstract available
    
    
14. VOUTOURI C, Munn LL, Stylianopoulos T, Jain RK, et al
    Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactions.
    PLoS Comput Biol. 2025;21:e1013163.
    PubMed         Abstract available
    
    
15. DEICHMANN J, Barda N, Canetti M, Peretz Y, et al
    Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data.
    PLoS Comput Biol. 2025;21:e1013192.
    PubMed         Abstract available
    
    

    
    PLoS One

16. PITOL AK, Venkatesan S, Richards S, Hoptroff M, et al
    SARS-CoV-2 survival on skin and its transfer from contaminated surfaces.
    PLoS One. 2025;20:e0325235.
    PubMed         Abstract available
    
    
17. FISH LE, Roberts SC, Bennett TD, Carlson NE, et al
    Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment.
    PLoS One. 2025;20:e0325991.
    PubMed         Abstract available
    
    
18. RUSSELL S, Munro K, Foulkes S, Broad J, et al
    Adapting COVID-19 research infrastructure to capture influenza and RSV alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Evaluation of the SIREN Winter Pressures pilot study.
    PLoS One. 2025;20:e0310758.
    PubMed         Abstract available
    
    
19. ZHU L, Zhong L, Huang G
    Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0326777.
    PubMed         Abstract available
    
    
20. LUNDA O, Chauke L, Daef G, Olorunfemi G, et al
    Maternal deaths before and during COVID-19 pandemic: Causes and avoidable factors in a tertiary hospital in South Africa, 2018?2022.
    PLoS One. 2025;20:e0326424.
    PubMed         Abstract available
    
    
21. MURPHY J, Livings MS, Wong M, Huang J, et al
    The association between community solidarity and adoption of public health preventive measures during the COVID-19 pandemic in a cross-sectional, multi-national sample.
    PLoS One. 2025;20:e0324234.
    PubMed         Abstract available
    
    
22. VALLEE G, Xi D, Avramovic G, O'Kelly B, et al
    Evaluating the longitudinal physical and psychological health effects of persistent long Covid 3.5 years after infection.
    PLoS One. 2025;20:e0326790.
    PubMed         Abstract available
    
    
23. ZEBARDAST A, Sadeghi K, Nejati A, Zadheidar S, et al
    A targeted approach for multiplex detection of respiratory viruses in cases with severe acute respiratory infections by nanopore sequencing.
    PLoS One. 2025;20:e0324601.
    PubMed         Abstract available
    
    
24. MANCHEL A, Erdemir A, Mulugeta L, Ku JP, et al
    A rubric for assessing conformance to the Ten Rules for credible practice of modeling and simulation in healthcare.
    PLoS One. 2025;20:e0313711.
    PubMed         Abstract available
    
    
25. DEMIRKIRAN B, Isin A, Sungur Y, Melekoglu T, et al
    The impact of 8-week re-training following a 14-week period of training cessation on Greco-Roman Wrestlers.
    PLoS One. 2025;20:e0326731.
    PubMed         Abstract available
    
    
26. AMELINE AS, Chandra DN, Htet MK, Zahra NL, et al
    Prevalence and factors associated with anemia among pregnant women during the COVID-19 pandemic in East Lombok district, Indonesia.
    PLoS One. 2025;20:e0323942.
    PubMed         Abstract available
    
    
27. AQEEL I, Majid A, Alahmadi TJ, Althubaity A, et al
    In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19.
    PLoS One. 2025;20:e0325707.
    PubMed         Abstract available
    
    
28. WHARTON E, O'Brien T, Foster RJ, Giebel C, et al
    "I don't know if it makes a difference to safety?" perception vs actuality: A mixed-methods study on older adults' experiences of home stair falls revealed during COVID-19 lockdown.
    PLoS One. 2025;20:e0326850.
    PubMed         Abstract available
    
    
29. AUNG KT, Htun YM, Htet ZL, Soe YNM, et al
    Parental hesitancy on COVID-19 vaccination of children under the age of 16: A cross-sectional mixed-methods study among factory workers.
    PLoS One. 2025;20:e0327056.
    PubMed         Abstract available
    
    
30. NGUYEN QT, Nguyen MPN, Bui NY, Ngo MQ, et al
    The complex interplay of personal and external factors in medical students' specialty decision-making: A qualitative study.
    PLoS One. 2025;20:e0326932.
    PubMed         Abstract available
    
    
31. OLARTE L, Lee B, Banerjee D, Swanson DS, et al
    Pneumococcal colonization dynamics among young children with and without respiratory symptoms during the first year of the SARS-CoV-2 pandemic.
    PLoS One. 2025;20:e0327046.
    PubMed         Abstract available
    
    
32. JEONG JY, Jeong YM
    Health behavior and mental health by gender in Korean adults before, during, and after the COVID-19 pandemic.
    PLoS One. 2025;20:e0325895.
    PubMed         Abstract available
    
    
33. BEKUMA TT, Seme A, Ahmed S, Abera M, et al
    Level and determinants of pentavalent vaccine dropout during infancy: A hierarchical analysis of community-level longitudinal study.
    PLoS One. 2025;20:e0326684.
    PubMed         Abstract available
    
    
34. VERLY-MIGUEL M, Lopes CS, Freitas JV, Garcia MC, et al
    Depression, anxiety and change in eating habits during the COVID-19 pandemic in Brazilian university students.
    PLoS One. 2025;20:e0326856.
    PubMed         Abstract available
    
    
35. AL SUFIAN SHUVO A, Maekawa Y, Kassai M, Kawahara T, et al
    Inhibitory effects of a hot-water extract of cumin fruit on influenza A virus infection.
    PLoS One. 2025;20:e0326423.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

36. JURASZEK J, Kadam RU, Branduardi D, van Ameijde J, et al
    De novo design of D-peptide ligands: Application to influenza virus hemagglutinin.
    Proc Natl Acad Sci U S A. 2025;122:e2426554122.
    PubMed         Abstract available
    
    
37. GUTMANN T, Kuster D, Hyman AA
    SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.
    Proc Natl Acad Sci U S A. 2025;122:e2426204122.
    PubMed         Abstract available
    
    

    
    Vaccine

38. SONG Z, Ma Y, Jiao L, Yu R, et al
    Lovastatin enhanced immune response to avian influenza vaccine in chickens and changed mRNA expression in the bursa of fabricius.
    Vaccine. 2025;61:127438.
    PubMed         Abstract available
    
    
39. SHINJOH M, Tamura K, Yamaguchi Y, Fukushima H, et al
    Influenza vaccination in Japanese children, 2024/25: Effectiveness of inactivated vaccine and limited use of newly introduced live-attenuated vaccine.
    Vaccine. 2025;61:127429.
    PubMed         Abstract available
    
    
40. SAMY A, Alber A, Fife M, Hammond JA, et al
    IFITM knockout DF1 cells produce higher influenza and newcastle disease viral yields: a proof of concept for avian origin cell-based vaccine production.
    Vaccine. 2025;61:127360.
    PubMed         Abstract available
    
    
41. MISHINA M, Cao W, Ende Z, Sharma SS, et al
    Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel.
    Vaccine. 2025;61:127361.
    PubMed         Abstract available
    
    

    
    Virology

42. BRUNO A, de Mora D, Olmedo M, Garces J, et al
    Highly pathogenic avian influenza A (H5N1) virus outbreaks in South America in 2022-2024: a comprehensive review of an ongoing panzootic.
    Virology. 2025;610:110602.
    PubMed         Abstract available
    
    
43. NGUYEN XD, Le B, Yang Q, Wang B, et al
    PathoSift Pro: A novel size-based bioaerosol sampler for effectively detecting infectious airborne influenza virus.
    Virology. 2025;610:110609.
    PubMed         Abstract available
    
    
44. PASQUALE S, Moscara L, Palmieri C, Martinelli A, et al
    Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024.
    Virology. 2025;610:110613.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.